If reports are to be believed then the only way to stop infection of Omicron is the Moderna vaccine. The vaccine giant Moderna that is presently supplying vaccines to a few countries globally seems to hold a lot of promise. Some reports have even claimed a 37-times increase in power to stop the Omicron variant. The laboratory reports and research seem to be doing all the talking. It is believed by experts that the vaccine can lead to a huge increase in antibodies within a month of receiving the booster shot.
Moderna Vaccine Seems To Hold Promise In Stopping Omicron Infections
In recent laboratory studies, the vaccine giant gave booster shots to 20 participants. The current FDA-approved booster quantity seems to be 50 mg.
A lot of patients received the 100 mg dose of the same. After 30 days, when the sample was studied, it was seen that all those who received 50 mg had their antibodies raised 37 times, and the 100 mg dosed participants had an 83 times surge in antibodies in their bodies.
If one considers the side effects, they tend to be the same as with the initial two doses. However, the 100 mg shot raised the probability of the side effects to a higher extent than the 50 mg one. The results have come amidst surges in the Omicron variant around the world. It is supposedly evading the other vaccines, like AstraZeneca, and Johnson and Johnson, to name a few. Every country has come up with a special vaccine that does not seem to hold well against the more contagious Omicron variant.
Dramatic Increase In Omicron Concerning
The huge surge in Omicron infection numbers is concerning to a lot of people today. However, the reports of Moderna making a huge impact in stopping the infection are surely a matter to celebrate. To meet the demands of the virus and the markets in general, Moderna is continuing to boost its efforts in bringing out the Moderna Booster dose. Continuous clinical trials are taking place to improve upon the infection-fighting powers of the vaccine.
A spokesperson from the Massachusetts-based company has said that the Federal regulators will decide whether to increase the dose of the 50-mg to 100- mg or leave it s it is. The clinical trials and more participants’ data will only be the basis to decide on the further course of action. It is not very clear whether the antibodies remain in high concentration for a considerable length of time or not. The participants have not been followed up beyond a month to ascertain the condition thereafter.
Moreover, the clinical trials were performed under laboratory conditions. It does not show whether the same results will be arrived at, in reality. The authorities have to still look at various ways, to determine the extent of hospitalization or death in numbers. Moderna, the vaccine maker has said that seeing the rapid surge in the number of Omicron in the countries across the globe, it’s stepping up operations.
The firm is also in the process to develop Omicron-centric boosters. That will supposedly have a better action than Moderna boosters for general Covid. The company is ramping up its strategy to study the immune-response escaping capabilities of the Omicron variant as well.
Some time back, Dr. Fauci, one of the doctors closely monitoring the case, had said that there is no need for a special Omicron-specific booster. However, the company Moderna seems to have a different idea about the whole scenario. In the meanwhile, the researchers are trying to find out more data on the variant and its escaping features, so as to come up with a great solution.
